Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia

This publication has 44 references indexed in Scilit:

• Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
  Nature Genetics, 2005
• Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile
  Genes, Chromosomes and Cancer, 2005
• Targeting signal transduction pathways by chemopreventive agents
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
• Pifithrin-? promotes p53-mediated apoptosis in JB6 cells
  Molecular Carcinogenesis, 2003
• An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo
  Nature Genetics, 2003
• Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment
  Blood, 2002
• ACUTE MYELOID LEUKEMIA: TREATMENT OVER 60
  Reviews in Clinical and Experimental Hematology, 2002
• Mutations in the p53 Gene in Acute Myeloid Leukemia Patients Correlate with Poor Prognosis
  Hematology, 2002
• In leukaemic CD5⁺ B cells the expression of BCL‐2 gene family is shifted toward protection from apoptosis
  British Journal of Haematology, 1996
• Over‐expression of the MDM₂ gene is found in some cases of haematological malignancies
  British Journal of Haematology, 1994